Executive Director of Global Value and Market Access

Company: Initial Therapeutics, Inc.
Location: San Francisco
Posted on: May 24, 2025

Job Description:

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease.
Position

• The Executive Director Global Value and Market Access will be responsible for developing and executing differentiated global market access and pricing strategies demonstrating the value of our assets to HTA bodies and payers to ensure optimal patient access. The ideal candidate will have a solid analytical background, strategic thinking as well as a deep understanding of US / EU /Japan/ Canada regional healthcare systems, payer preferences, and market dynamics to lead the market access and pricing launch strategies.
  Responsibilities
  
  • Lead the development of Global Integrated Access and Pricing strategies in collaboration with the cross-functional team to maximize the value of assigned asset(s),
  • Provide strategic market access input to inform global clinical development program of assigned asset(s) and ensure it is optimized to meet the needs of global payers (e.g., relevant endpoints, trial design, sub-populations, evidence of cost offsets) by incorporating HTA and payers' perspectives gained through early HTA engagement, ad boards, primary payer research, and analysis of select secondary research,
  • Develop and maintain strong business relationships with key functions responsible for value proposition enablement with a focus on clinical, commercial, regulatory, medical affairs, and HEOR stakeholders,
  • Proactively identify and communicate evidence requirements for successful access and support the development of evidence generation plans in collaboration with HEOR,
  • Collaborate with Market Access colleagues (Global and in countries) to drive alignment, optimize support, and promote efficiency and best practice sharing,
  • Monitor, analyze and communicate Global market access and pricing trends, competitor activities, and policy changes to anticipate future market dynamics and adjust strategies accordingly,
  • Support the execution of broader market access goals, including pricing targets, access timelines, and overall launch success,
  • Plan and contribute to JCA submission.
    Requirements
    
    • Ph. D, Pham D, M. Sc. in appropriate field (Health Economics, Public Health, or Health Policy) preferred.
    • +10 years of relevant experience working within a similar organization including international exposure within a leadership position,
    • Strong experience in pricing and reimbursement of hematology / oncology products with specific knowledge of and demonstrated experience in one of the key HTA markets (i.e., UK, Germany, France, Canada),
    • Strong experience with pricing regulations and a hands-on role in early and launch Pricing analysis. Hands-on experience with country pricing negotiations is a plus,
    • Demonstrable experience supporting the early global development plans to meet the evidence requirements for the various downstream market access stakeholders,
    • Proven track record of success within developing desirable value propositions and access strategies,
    • Demonstrated knowledge of global policy trends, tactics, and HTA/payer dynamics incl. regional developments (e.g., JCA, IRA),
    • Experience in making market access recommendations on products in development and suggesting changes for optimization of market access,
    • Demonstrated success in managing multiple activities (both "self" and through delegation) and working in a fast-paced environment,
    • Proven track record of providing thought leadership, influencing decisions across all levels of the organization, and driving results through teams,
    • Fluency in English and an additional language would be a strong advantage.
      Fit with Nurix Culture and Values
      • Strong team orientation; highly collaborative
      • Solutions and results-oriented focus
      • Hands-on approach; resourceful and open to diverse points of view
        Application ProcessNurix is an Equal Opportunity Employer offering a competitive salary and benefits package. Applicants should be legally entitled to work for any employer in the US.Nurix Therapeutics, Inc. is committed to protecting and respecting your privacy and personal information, including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix. By applying for a position at Nurix, you agree to our collection and use of personal information as described in our Privacy Policy ().
        #J-18808-Ljbffr

Keywords: Initial Therapeutics, Inc., Oakland , Executive Director of Global Value and Market Access, Executive , San Francisco, California